Cincinnati biopharma startup lands massive $143M round

Cincor-website-screenshot-homepage

A Cincinnati company developing treatments for hypertension and other diseases has raised a $143 million Series B — the second startup in the region to land a nine-figure fund raise so far this year.

Madisonville-based CinCor Pharma, a clinical-stage biopharmaceutical company developing treatments for cardio-renal diseases, announced the funding Tuesday, bringing its total amount raised to $193 million.

The $143 million Series B ranks as the second-highest capital raise in the region’s history, and comes two months after 80 Acres, a Hamilton-based vertical farming startup, raised a record-high $160 million in August.

Click here to read the complete story.

Story excerpt provided by Cincy Inno.

Written by Liz Engel.

Originally published October 12, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: